Dr. Daniel Bernard Groblewski, MD

Dr. Groblewski practices at HCA Florida Memorial Hospital in Jacksonville, Florida, part of HCA Healthcare.

Dr. Groblewski's NPI, 1821179888, was assigned on October 18, 2006. Dr. Groblewski graduated from Brody School Of Medicine At East Carolina University in 1992. Dr. Groblewski holds Florida license ME82674.

Dr. Groblewski's primary practice is HCA Florida Memorial Hospital, at 3625 University Blvd S, Jacksonville, FL 32216 in Duval County. The practice phone is (904) 702-6111.

Dr. Groblewski's primary practice is HCA Florida Memorial Hospital in Jacksonville, Florida, part of HCA Healthcare. Dr. Groblewski is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is HCA Florida Jacksonville Primary Care. Dmand AI also links Dr. Groblewski to 1 more hospital and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Groblewski practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Groblewski's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Groblewski is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Groblewski's licenses on file in 3 states: Florida, South Carolina and Georgia.

Dmand AI lists alzheimer's disease, cerebrovascular disease, encephalopathy, epilepsy, essential tremor, fibromyalgia and chronic pain, hereditary polyneuropathy and lower back pain among the conditions Dr. Groblewski treats.

CMS data shows 1,133 Medicare services from Dr. Groblewski across 8 procedure codes in 2024, for 523 Medicare patients. Medicare paid $96,791 for them.

CMS counts 523 Medicare patients who saw Dr. Groblewski in 2024. The largest group is 75 to 84, with 203 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Groblewski's median patient age at 68, with 61% women.

In 2024, Dr. Groblewski wrote 2,158 Medicare Part D claims for 218 patients. 91% of them were for generic drugs. CMS names the drug for 1,973 of them, across 55 drugs with 11 or more claims each, at $558,464 in total drug cost. In 2023, CMS named 2,216 claims across 51 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Groblewski for performance year 2024, reported as part of a group. Dr. Groblewski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Groblewski as offering telehealth.

CMS Open Payments shows 1,002 general payments to Dr. Groblewski from 62 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $1,310.

Dmand AI lists 1 award for Dr. Groblewski, most recently Regional Top Doctor in 2014.

Dr. Groblewski graduated from Brody School Of Medicine At East Carolina University in 1992. Dr. Groblewski is a member of AAN and Florida Medical Association.

Dr. Groblewski is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.